Literature DB >> 14065958

CURRENT STUDIES ON THE EFFECT ANTIMETABOLITES IN NEPHROSIS, OTHER NON-NEOPLASTIC DISEASES, AND EXPERIMENTAL ANIMALS. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.

H C GOODMAN, S M WOLFF, R R CARPENTER, B R ANDERSEN, M W BRANDRISS.   

Abstract

Entities:  

Keywords:  AGAMMAGLOBULINEMIA; ALANINE AMINOTRANSFERASE; ANTIMETABOLITES; AUTOIMMUNE DISEASES; ENCEPHALOMYELITIS; ENZYME TESTS; HEPATITIS; HYPERSENSITIVITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MERCAPTOPURINE; NEPHROSIS; NEPHROTIC SYNDROME; PREDNISONE; SKIN TESTS

Mesh：

Substances：

Year:  1963        PMID： 14065958     DOI： 10.7326/0003-4819-59-3-388

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

1.  Is azathioprine a better immunosuppressive than 6-mercaptopurine?

Authors:  M C Berenbaum
Journal:  Clin Exp Immunol       Date:  1971-01       Impact factor: 4.330

2.  Management of the nephrotic syndrome.

Authors:  G C Arneil
Journal:  Arch Dis Child       Date:  1968-04       Impact factor: 3.791

3.  Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.

Authors:  K N Drummond; D A Hillman; J H Marchessault; W Feldman
Journal:  Can Med Assoc J       Date:  1968-03-16       Impact factor: 8.262

4.  Mercaptopurine-dependent remission of nephrotic syndrome.

Authors:  J F Maher
Journal:  Br Med J       Date:  1970-06-13

5.  Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome.

Authors:  R H White; J S Cameron; J R Trounce
Journal:  Br Med J       Date:  1966-10-08

6.  Refractory nephrotic syndrome.

Authors:  R K Chandra
Journal:  Indian J Pediatr       Date:  1966-11       Impact factor: 1.967

7.  Cutaneous manifestations of autoimmune disease.

Authors:  J L Callaway
Journal:  J Natl Med Assoc       Date:  1965-03       Impact factor: 1.798

8.  Immunosuppressive therapy in polymyositis.

Authors:  S Currie; J N Walton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-08       Impact factor: 10.154
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.